Reuters logo
BRIEF-Miragen Therapeutics Q2 loss per share $0.34
August 11, 2017 / 8:07 PM / a month ago

BRIEF-Miragen Therapeutics Q2 loss per share $0.34

Aug 11 (Reuters) - Miragen Therapeutics Inc

* Miragen Therapeutics reports second quarter 2017 financial results and provides corporate update

* Q2 loss per share $0.34

* Q2 revenue $700,000 versus $1.1 million

* Miragen Therapeutics Inc - expects that its current cash and cash equivalents will be sufficient to fund its operations through end of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below